Hydrogen sulfide and the pathogenesis of atherosclerosis

Antioxidants and Redox Signaling

Volumn 20, Issue 5, 2014, Pages 805-817

  Mani, Sarathi ^a   Untereiner, Ashley ^a,b   Wu, Lingyun ^a,b   Wang, Rui ^a  

^a LAKEHEAD UNIVERSITY   (Canada)

^b Thunder Bay Regional Research Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 MERCAPTOPYRUVATE SULFURTRANSFERASE; CELL ADHESION MOLECULE; CYCLIN D1; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; CYSTEINE AMINOTRANSFERASE; HOMOCYSTEINE; HYDROGEN SULFIDE; REACTIVE OXYGEN METABOLITE; TRANSFERASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTERY CALCIFICATION; ATHEROSCLEROSIS; CELL HYPERPLASIA; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; DYSLIPIDEMIA; ENDOTHELIUM CELL; FOAM CELL; HUMAN; LIPID METABOLISM; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT SAFETY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; SMOOTH MUSCLE FIBER; THERAPY EFFECT; THROMBOCYTE ACTIVATION; VASCULAR DISEASE; VASCULITIS;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMANS; HYDROGEN SULFIDE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; SIGNAL TRANSDUCTION; VASCULAR CALCIFICATION;

EID: 84893453992     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5324     Document Type: Review

References (119)

1. Amin MA, Volpert OV, Woods JM, Kumar P, Harlow LA, and Koch AE. Migration inhibitory factor mediates angio-genesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res 93: 321-329, 2003. (Pubitemid 37048244)
2. Antoniades C, Tousoulis D, and Stefanadis C. Effects of endothelial nitric oxide synthase gene polymorphisms on oxidative stress, inflammatory status, and coronary atherosclerosis: an example of a transient phenotype. J Am Coll Cardiol 49: 1226-1227, 2007.
3. Assmann G and Schulte H. Role of triglycerides in coronary artery disease: lessons from the prospective cardiovascular munster study. Am J Cardiol 70: 10H-13H, 1992. (Pubitemid 23006057)
4. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 11: 2-14, 1991.
5. Austin RC, Lentz SR, and Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 11 Suppl I: S56-S64, 2004. (Pubitemid 39136799)
6. Au-Yeung KK, Woo CW, Sung FL, Yip JC, Siow YL, and Karmin O. Hyperhomocysteinemia activates nuclear factorkappaB in endothelial cells via oxidative stress. Circ Res 94: 28-36, 2004. (Pubitemid 38064095)
7. Ballantyne CM and Entman ML. Soluble adhesion molecules and the search for biomarkers for atherosclerosis. Circulation 106: 766-767, 2002.
8. Baskar R, Sparatore A, Del Soldato P, and Moore PK. Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation. Eur J Pharmacol 594: 1-8, 2008.
9. Beauchamp RO, Bus JS, Popp JA, Boreiko CJ, and Andjelkovich DA. A critical review of the literature on hydrogen sulfide toxicity. Crit Rev Toxicol 13: 25-97, 1984. (Pubitemid 14069476)
10. Beck JF, Donini JC, and Maneckjee A. The influence of sulfide and cyanide on axonal function. Toxicology 26: 37-45, 1983. (Pubitemid 13153380)
11. Benavides GA, Squadrito GL, Mills RW, Patel HD, Isbell TS, Patel RP, Darley-Usmar VM, Doeller J, and Kraus DW. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci USA 104: 17977-17982, 2007. (Pubitemid 350210806)
12. Boisvert WA. Modulation of atherogenesis by chemokines. Trends Cardiovasc Med 14: 161-165, 2004. (Pubitemid 38737336)
13. Bourdillon MC, Poston RN, Covacho C, Chignier E, Bricca G, and McGregor JL. ICAM-1 deficiency reduces atherosclerotic lesions in double-knockout mice (ApoE-/-/ICAM-1-/-) fed a fat or a chow diet. Arterioscler Thromb Vasc Biol 20: 2630-2635, 2000.
14. Burnett G, Marcotte P, and Walsh C. Mechanism-based inactivation of pig heart L-alanine transaminase by Lpropargylglycine. J Biol Chem 255: 3487-3491, 1980.
15. Cai WJ, Wang MJ, Moore PK, Jin HM, Yao T, and Zhu YC. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res 76: 29-40, 2007. (Pubitemid 47362041)
16. Chambers JC, McGregor A, Jean-Marie J, Mbeid OA, and Kooner JS. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 99: 1156-1160, 1999. (Pubitemid 29120086)
17. Chang L, Geng B, Yu F, Zhao J, Jiang H, Du J, and Tang C. Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats. Amino Acids 34: 573-585, 2008.
18. Chang T, Untereiner A, Liu J, and Wu L. Interaction of methylglyoxal and hydrogen sulfide in rat vascular smooth muscle cells. Antioxid Redox Signal 12: 1093-1100, 2010.
19. Constans J and Conri C. Circulating markers of endothelial function in cardiovascular disease. Clin Chim Acta 368: 33-47, 2006. (Pubitemid 43792418)
20. Crowley ST, Ray CJ, Nawaz D, Majack RA, and Horwitz LD. Multiple growth factors are released from mechanically injured vascular smooth muscle cells. Am J Physiol 269: H1641-H1647, 1995. (Pubitemid 3005968)
21. Dimmeler S and Zeiher AM. Akt takes center stage in angiogenesis signaling. Circ Res 86: 4-5, 2000. (Pubitemid 30044160)
22. Doran AC, Meller N, and McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28: 812-819, 2008. (Pubitemid 351544093)
23. Du J, Hui Y, Cheung Y, Bin G, Jiang H, Chen X, and Tang C. The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart Vessels 19: 75-80, 2004. (Pubitemid 38489034)
24. Dzau VJ, Braun-Dullaeus RC, and Sedding DG. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 8: 1249-1256, 2002. (Pubitemid 35373556)
25. Essex DW. The role of thiols and disulfides in platelet function. Antioxid Redox Signal 6: 736-746, 2004. (Pubitemid 38890791)
26. Fiorucci S, Antonelli E, Distrutti E, Rizzo G, Mencarelli, Orlandi S, Zanardo R, Renga B, Di Sante M, Morelli A, Cirino G, and Wallace JL. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by antiinflammatory nonsteroidal drugs. Gastroenterology 129: 1210-1224, 2005. (Pubitemid 41446861)
27. Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, and Hansson GK. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145: 33-43, 1999. (Pubitemid 29292698)
28. Geng B, Cui Y, Zhao J, Yu F, Zhu Y, Xu G, Zhang Z, Tang C, and Du J. Hydrogen sulfide downregulates the aortic L-arginine/nitric oxide pathway in rats. Am J Physiol Regul Integr Comp Physiol 293: R1608-R1618, 2007. (Pubitemid 47535779)
29. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695, 2005.
30. Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, Ferran LJ Jr., Kohl B, Rao V, Kisiel W, Stern DM, and Schmidt AM. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 107: 675-683, 2001. (Pubitemid 32225353)
31. Hwang J, Saha A, Boo YC, Sorescu GP, McNally JS, Holland SM, Dikalov S, Giddens DP, Griendling KK, Harrison DG, and Jo H. Oscillatory shear stress stimulates endothelial production of O2-from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. J Biol Chem 278: 47291-47298, 2003. (Pubitemid 37452318)
32. Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, Doi K, Ogawa Y, Tamura N, Takaya K, Igaki T, Yamashita J, Chun TH, Masatsugu K, Becker AE, and Nakao K. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 98: 2108-2116, 1998. (Pubitemid 28527469)
33. Issbrü cker K, Marti HH, Hippenstiel S, Springmann G, Voswinckel R, Gaumann A, Breier G, Drexler HC, Suttorp N, and Clauss M. p38 MAP kinase-a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB J 17: 262-264, 2003.
34. Jain SK, Bull R, Rains JL, Bass PF, Levine SN, Reddy S, McVie R, and Bocchini JA. Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation? Antioxid Redox Signal 12: 1333-1337, 2010.
35. Jeney V, Komó di E, Nagy E, Zarjou A, Vercellotti GM, Eaton JW, Balla G, and Balla J. Suppression of heminmediated oxidation of low-density lipoprotein and subsequent endothelial reactions by hydrogen sulfide (H2S). Free Radic Biol Med 46: 616-623, 2009.
36. Kamoun P, Belardinelli MC, Chabli A, Lallouchi K, and Chadefaux-Vekemans B. Endogenous hydrogen sulfide overproduction in Down syndrome. Am J Med Genet 116A: 310-311, 2003. (Pubitemid 36056753)
37. Karamysheva AF. Mechanisms of angiogenesis. Biochemistry (Mosc) 73: 751-762, 2008.
38. KinlayS, Libby P, and Ganz P. Endothelial function and coronary artery disease. Curr Opin Lipidol 12: 383-389, 2001. (Pubitemid 32675498)
39. Korhonen T, Savolainen MJ, Koistinen MJ, Ikäheimo M, Linnaluoto MK, Kervinen K, and Kesäniemi YA. Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women. Atherosclerosis 127: 213-220, 1996. (Pubitemid 27046630)
40. Laggner H, Muellner MK, Schreier S, Sturm B, Hermann M, Exner M, Gmeiner BM, and Kapiotis S. Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOCl. Free Radic Res 41: 741-747, 2007. (Pubitemid 46995255)
41. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, and Heistad DD. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest 98: 24-29, 1996. (Pubitemid 26243816)
42. Li AC and Glass CK. The macrophage foam cell as a target for therapeutic intervention. Nat Med 8: 1235-1242, 2002. (Pubitemid 35373554)
43. Li J, Chai S, Tang C, and Du J. Homocysteine potentiates calcification of cultured rat aortic smooth muscle cells. Life Sci 74: 451-461, 2003. (Pubitemid 37377900)
44. Li L, RossoniG, Sparatore A, Lee LC,Del Soldato P, andMoore PK. Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic BiolMed 42: 706-719, 2007. (Pubitemid 46205152)
45. Li T, Zhao B, Wang C, Wang H, Liu Z, Li W, Jin H, Tang C, and Du J. Regulatory effects of hydrogen sulfide on IL-6, IL-8 and IL-10 levels in the plasma and pulmonary tissue of rats with acute lung injury. Exp Biol Med 233: 1081-1087, 2008.
46. Li W, Tang C, Jin H, and Du J. Regulatory effects of sulfur dioxide on the development of atherosclerotic lesions and vascular hydrogen sulfide in atherosclerotic rats. Atherosclerosis 215: 323-330, 2011.
47. Li W, Jin HF, Liu D, Sun JH, Jian PJ, Li XH, Tang CS, and DU JB. Hydrogen sulfide induces apoptosis of pulmonary artery smooth muscle cell in rats with pulmonary hypertension induced by high pulmonary blood flow. Chin Med J 122: 3032-3038, 2009.
48. Libby P. Inflammation in atherosclerosis. Nature 420: 868-874, 2002. (Pubitemid 36019640)
49. Lum H and Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 280: C719-C741, 2001.
50. Luscher TF and Barton M. Biology of the endothelium. Clin Cardiol 20: II3-II10, 1997. (Pubitemid 28009557)
51. Madamanchi NR, Vendrov A, and Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25: 29-38, 2005. (Pubitemid 40054251)
52. Majors AK, Sengupta S, Jacobsen DW, and Pyeritz RE. Upregulation of smooth muscle cell collagen production by homocysteine-insight into the pathogenesis of homocystinuria. Mol Genet Metab 76: 92-99, 2002. (Pubitemid 34759999)
53. Mani S, Yang G, and Wang R. A critical life-supporting role for cystathionine c-lyase in the absence of dietary cysteine supply. Free Radic Biol Med 50: 1280-1287, 2011.
54. Meng QH, Yang G, Yang W, Jiang B, Wu L, and Wang R. Protective effect of hydrogen sulfide on balloon injury-induced neointima hyperplasia in rat carotid arteries. Am J Pathol 170: 1406-1414, 2007. (Pubitemid 47339347)
55. Miller GL and Miller NE. Plasma high-density lipoprotein concentration and the development of ischaemic heart disease. Lancet 1: 16-19, 1975.
56. Mody N, Parhami F, Sarafian TA, and Demer LL. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radical Biol Med 31: 509-519, 2001. (Pubitemid 32728438)
57. Muellner MK, Schreier SM, Laggner H, Hermann M, Esterbauer H, Exner M, Gmeiner BM, and Kapiotis S. Hydrogen sulfide destroys lipid hydroperoxides in oxidized LDL. Biochem J 420: 277-281, 2009.
58. Muzaffar S, Shukla N, Bond M, Newby AC, Angelini GD, Sparatore A, Del Soldato P, and Jeremy JY. Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells. J Vasc Res 45: 521-528, 2008.
59. Namekata K, Enokido Y, Ishii I, Nagai Y, Harada T, and Kimura H. Abnormal lipid metabolism in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia. J Biol Chem 279: 52961-52969, 2004. (Pubitemid 40051794)
60. Nandalur KR, Baskurt E, Hagspiel KD, Phillips CD, and Kramer CM. Calcified carotid atherosclerotic plaque is associated less with ischemic symptoms than is noncalcified plaque on MDCT. Am J Roentgenol 184: 295-298, 2005. (Pubitemid 40040945)
61. Norata GD, Tonti L, Roma P, and Catapano AL. Apoptosis and proliferation of endothelial cells in early atherosclerotic lesions: possible role of oxidised LDL. Nutr Metab Cardiovasc Dis 12: 297-305, 2002. (Pubitemid 135713574)
62. Oh GS, Pae HO, Lee BS, Kim BN, Kim JM, Kim HR, Jeon SB, JeonWK, Chae HJ, and Chung HT. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-jB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic BiolMed 41: 106-119, 2006. (Pubitemid 43884782)
63. Ortiz MI, Castañ eda-Hernández G, Rosas R, Vidal-Cantú GC, and Granados-Soto V. Evidence for a new mechanism of action of diclofenac: activation of K+ channels. Proc West Pharmacol Soc 44: 19-21, 2001. (Pubitemid 34087699)
64. Pan LL, Liu XH, Gong QH, Wu D, and Zhu YZ. Hydrogen sulfide attenuated tumor necrosis factor-a-induced inflammatory signaling and dysfunction in vascular endothelial cells. PLoS One 6: e19766, 2011.
65. Paoletti R, Gotto AM Jr., and Hajjar DP. Inflammation in atherosclerosis and implications for therapy. Circulation 109: III20-III26, 2004. (Pubitemid 38786439)
66. Papapetropoulos A, Pyriochou A, Altaany Z, Yang G, Marazioti A, Zhou Z, Jeschke MG, Branski LK, Herndon DN, Wang R, and Szabó C. Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci USA 106: 21972-21977, 2009.
67. Plump AS, Smith JD, Hayek T, Aalto-Setä lä K, Walsh A, Verstuyft JG, Rubin EM, and Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353, 1992.
68. Poddar R, Sivasubramanian N, Dibello PM, Robinson K, and Jacobsen D. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 103: 2717-2723, 2001. (Pubitemid 32538788)
69. Pyiochou A, Papapetropoulos A, Olah G, Wintner E, Jeschke M, Branski L, Herndon D, Traber D, and Szabo C. The hydrogen sulfide donor IK-1001 stimulates neovascularization and improves wound healing. FASEB J 22: 912.42, 2008.
70. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126, 1999.
71. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809, 1993. (Pubitemid 23132154)
72. Rudel LL and Kesainiemi A. Low-density lipoprotein particle composition: what is the contribution to atherogenicity? Curr Opin Lipidol 11: 227-228, 2000. (Pubitemid 30336018)
73. Saku K, Zhang B, Ohta T, and Arakawa K. Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis. J Am Coll Cardiol 33: 436-443, 1999. (Pubitemid 29234206)
74. Schwartz SM, deBlois D, and O'Brien ER. The intima. Soil for atherosclerosis and restenosis. Circ Res 77: 445-465, 1995.
75. Szabó C and Papapetropoulos A. Hydrogen sulphide and angiogenesis: mechanisms and applications. Br J Pharmacol 164: 853-865, 2011.
76. Taha S, Azzi A, and Ozner NK. Homocysteine induces DNA synthesis and proliferation of vascular smooth muscle cells by a hydrogen peroxide-independent mechanism. Antioxid Redox Signal 1: 365-369, 1999. (Pubitemid 129622806)
77. Tanase S and Morino Y. Irreversible inactivation of aspartate aminotransferase during transamination with Lpropargylglycine. Biochem Biophys Res Commun 68: 1301-1308, 1976.
78. Tang G, Wu L, Liang W, and Wang R. Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol 68: 1757-1764, 2005. (Pubitemid 41654358)
79. Tawakol A, Omland T, Gerhard M, Wu JT, and Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilatation in humans. Circulation 95: 1119-1121, 1997. (Pubitemid 27097819)
80. Tousoulis D, Antoniades C, and Stefanadis C. Assessing inflammatory status in cardiovascular disease. Heart 93: 1001-1007, 2007. (Pubitemid 47122060)
81. Tritto I and Ambrosio G. The multi-faceted behavior of nitric oxide in vascular "inflammation": catchy terminology or true phenomenon? Cardiovasc Res 63: 1-4, 2004. (Pubitemid 38759802)
82. Truong DH, Eghbal MA, Hindmarsh W, Roth SH, and O'Brien PJ. Molecular mechanisms of hydrogen sulfide toxicity. Drug Metab Rev 38: 733-744, 2006. (Pubitemid 44903265)
83. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, and Lee ME. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci 91: 6369-6373, 1994. (Pubitemid 24200662)
84. Tuomisto TT, Binder BR, and Yla-Herttuala S. Genetics, genomics and proteomics in atherosclerosis research. Ann Med 37: 323-332, 2005. (Pubitemid 41379839)
85. Tyagi N, Moshai KS, Sen U, Vacek TP, Kumar M, Hughes WM Jr., Kundu S, and Tyagi SC. H2S protects against methionine-induced oxidative stress in brain endothelial cells. Antioxid Redox Signal 11: 25-33, 2009.
86. VanderLaan PA, Reardon CA, and Getz GS. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol 24: 12-22, 2004. (Pubitemid 38082406)
87. Wallace JL, Cirino G, Santagada V, and Caliendo G. 4-Hydroxythiobenzamide derivatives of drugs. Dec. 10, 2009 http://www.google.com/patents/ US20090306412?pg=PA11& dq=20090306412&hl=en&sa=X&ei= HnaOUejHCZPwq QHdoYHADw&ved=0CDcQ6AEwAA
88. Wallin R, Wajih N, Greenwood GT, and Sane DC. Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy.Med Res Rev 21: 274-301, 2001. (Pubitemid 32565495)
89. Wang H, Jiang X, Yang F, Gaubatz JW, Ma L, Magera MJ, Yang X, Berger PB, Durante W, Pownall HJ, and Schafer AI. Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation. Blood 101: 3901-3907, 2003. (Pubitemid 36857865)
90. Wang MJ, Cai WJ, Li N, Ding YJ, Chen Y, and Zhu YC. The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia. Antioxid Redox Signal 12: 1065-1077, 2010.
91. Wang MJ, Cai WJ, and Zhu YC. Mechanisms of angiogenesis: role of hydrogen sulphide. Clin Exp Pharmacol Physiol 37: 764-771, 2010.
92. Wang R.Physiological implications of hydrogen sulfide: awhiff exploration that blossomed. Physiol Rev 92: 791-896, 2012.
93. Wang R. Hydrogen sulfide: a new EDRF. Kidney Int 76: 700-704, 2009.
94. Wang R. Is H2S a stinky remedy for atherosclerosis? Arterioscler Thromb Vasc Biol 29: 156-157, 2009.
95. Wang Y, Zhao X, Jin H, Wei H, Li W, Bu D, Tang X, Ren Y, Tang C, and Du J. The role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein-E knockout mice. Arterioscler Thromb Vasc Biol 29: 173-179, 2009.
96. Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Malinow MR, and Maeda N. Mice deficient in cystathionine b-synthase: animal models for mild and severe homocyst( e)inemia. Proc Natl Acad Sci USA 92: 1585-1589, 1995.
97. Watts GF, Mandalia S, Brunt JNH, Slavin BM, Coltart DJ, and Lewis B. Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas'Atherosclerosis Regression Study (STARS). Metabolism 42: 1461-1467, 1993. (Pubitemid 23335880)
98. Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, Zhou J, Maeda N, Krisans SK, Malinow MR, and Austin RC. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 107: 1263-1273, 2001. (Pubitemid 32494543)
99. Whiteman M, Li L,Rose P, Tan CH, Parkinson DB, and Moore PK. The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid Redox Signal 12: 1147-1154, 2010.
100. Witztum JL and Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88: 1785-1792, 1991.
101. Wu SY, Pan CS, Geng B, Zhao J, Yu F, Pang YZ, Tang CS, and Qi YF. Hydrogen sulfide ameliorates vascular calcification induced by vitamin D3 plus nicotine in rats. Acta Pharmacol Sin 27: 299-306, 2006. (Pubitemid 43357025)
102. Yan SK, Chang T, Wang H, Wu L, Wang R, and Meng QH. Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem Biophys Res Commun 351: 485-491, 2006. (Pubitemid 44755144)
103. Yang G, Li H, Tang G, Wu L, Zhao K, Cao Q, Xu C, and Wang R. Increased neointimal formation in cystathionine gamma-lyase deficient mice: role of hydrogen sulfide in a5b1-integrin and matrix metalloproteinase-2 expression in smooth muscle cells. J Mol Cell Cardiol 52: 677-688, 2012.
104. Yang G. Hydrogen sulfide in cell survival: a double-edged sword. Expert Rev Clin Pharmacol 4: 33-47, 2011.
105. Yang G, Pei Y, Teng H, Cao Q, and Wang R. Specificity protein-1 as a critical regulator of human cystathionine gamma-lyase in smooth muscle cells. J Biol Chem 286: 26450-26460, 2011.
106. Yang G, Wu L, Bryan S, Khaper N, Mani S, and Wang R. Cystathionine gamma-lyase deficiency and overproliferation of smooth muscle cells. Cardiovasc Res 86: 487-495, 2010.
107. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S, Snyder SH, and Wang R. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322: 587-590, 2008.
108. Yang G, Wu L, and Wang R. Pro-apoptotic effect of endogenous H2S on human aorta smooth muscle cells. FASEB J 20: 553-555, 2006. (Pubitemid 46671247)
109. Yang G, Sun X, and Wang R. Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogen-activated protein kinases and capase-3. FASEB J 18: 1782-1784, 2004. (Pubitemid 39561683)
110. Zagli G, Patacchini R, Trevisani M, Abbate R, Cinotti S, Gensini GF, Masotti G, and Geppetti P. Hydrogen sulfide inhibits human platelet aggregation. Eur J Pharmacol 559: 65-68, 2007. (Pubitemid 46274652)
111. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, and Wallace JL. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 20: 2118-2120, 2006.
112. Zavaczki E, Jeney V, Agarwal A, Zarjou A, Oros M, Katkó M, Varga Z, Balla G, and Balla J. Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells. Kidney Int 80: 731-739, 2011.
113. Zhang C, Cai Y, Adachi MT Oshiro S, Aso T, Kaufman RJ, and Kitajima S. Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem 276: 35867-35874, 2001.
114. Zhang H, Guo C, Wu D, Zhang A, Gu T, Wang L, and Wang C. Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression. PLoS One 7: e41147, 2012.
115. Zhang SH, Reddick RL, Piedrahita JA, and Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-471, 1992.
116. Zhao ZZ, Wang Z, Li GH, Wang R, Tan JM, Cao X, Suo R, and Jiang ZS. Hydrogen sulfide inhibits macrophagederived foam cell formation. Exp Biol Med 236: 169-176, 2011.
117. Zhi L, Ang AD, Zhang H, Moore PK, and Bhatia M. Hydrogen sulfide induces the synthesis of proinflammatory cytokines in human monocyte cell line U937 via the ERKNF-kappaB pathway. J Leukoc Biol 81: 1322-1332, 2007. (Pubitemid 46702052)
118. Zhou J, Moller J, Danielsen CC, Bentzon J, Ravn HB, Austin RC, and Falk E. Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 21: 1470-1476, 2001. (Pubitemid 34219810)
119. Zhu XY, Liu SJ, Liu YJ, Wang S, and Ni X. Glucocorticoids suppress cystathionine gamma-lyase expression and H2S production in lipopolysaccharide- treated macrophages. Cell Mol Life Sci 67: 1119-1132, 2010.